On Oct 27, 2021 Immunai closed a Series B round and raised $215,000,000 from 8VC, Alexandria Venture Investments, Icon Ventures, Koch Disruptive Technologies, Piedmont Capital, […]
Series A – SimBioSys
On Oct 26, 2021 SimBioSys closed a Series A round and raised $15,000,000 from AV8 Ventures, Genoa Ventures, Heritage Group, Mayo Clinic, Northpond Ventures, featuring […]
Post-IPO Equity – Ultimovacs
On Oct 26, 2021 Ultimovacs closed a Post-IPO Equity round and raised NOK270,000,000 from investors, featuring lead investors . About the company: Ultimovacs is located […]
Seed Round – Alveolus Bio
On Oct 26, 2021 Alveolus Bio closed a Seed round and raised $4,500,000 from investors, featuring lead investors . About the company: Alveolus Bio is […]
Post-IPO Equity – Kadimastem
On Oct 26, 2021 Kadimastem closed a Post-IPO Equity round and raised $5,000,000 from Alpha Capital Anstalt, Clover Wolf Capital, Julien Ruggieri, Michel Revel, featuring […]
Series A – Gencove
On Oct 26, 2021 Gencove closed a Series A round and raised $10,000,000 from Lewis & Clark AgriFood, Spero Ventures, Techammer, Third Kind Venture Capital, […]
Series C – Cambrian Biopharma
On Oct 26, 2021 Cambrian Biopharma closed a Series C round and raised $100,000,000 from Anthos Capital, Apeiron Investment Group, Future Ventures, Moore Capital, SALT […]
Series C – DNA Script
On Oct 26, 2021 DNA Script closed a Series C round and raised $165,000,000 from Agilent Technologies, Alexandria Venture Investments, ArrowMark Partners, Bpifrance, Casdin Capital, […]
Post-IPO Equity – Ultimovacs
On Oct 26, 2021 Ultimovacs closed a Post-IPO Equity round and raised NOK270,000,000 from investors, featuring lead investors . About the company: Ultimovacs is located […]
Series C – DNA Script
On Oct 26, 2021 DNA Script closed a Series C round and raised $165,000,000 from Agilent Technologies, Alexandria Venture Investments, ArrowMark Partners, Bpifrance, Casdin Capital, […]
